Nicolet Bankshares’s NovoCure NVCR Stock Holding History

Nicolet Bankshares’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-903	Closed	-$200K	–	210
2021 Q2	$200K	Buy	+903	New	+$176K	0.05%	204

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicolet Bankshares's NVCR Position: Q3 2021 in Review

Nicolet Bankshares sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 903 shares — an estimated $200K sold.

Nicolet Bankshares first reported a position in NVCR in Q2 2021 and held it in 1 quarter. The position peaked at $200K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

Nicolet Bankshares reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
Nicolet Bankshares sold 903 NovoCure shares in Q3 2021, an estimated $200K.
Nicolet Bankshares first reported a position in NovoCure in Q2 2021 and held it in 1 quarter.
Nicolet Bankshares's NovoCure position peaked at $200K in Q2 2021.
317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Nicolet Bankshares's 13F filing for Q3 2021, filed 16 Nov 2021.